PHI with Mayer-Rokitansky-Küster syndrome
How does this condition affect your private health insurance?
Mayer-Rokitansky-Küster-Syndrom (MRKH) is a congenital disorder affecting females, characterized by the absence or underdevelopment of the uterus and the upper two-thirds of the vagina. Individuals typically have normal ovaries, external genitalia, and a 46,XX karyotype. It is usually diagnosed during adolescence due to primary amenorrhea (absence of menstruation by age 15). While individuals with MRKH cannot carry a pregnancy due to the lack of a functional uterus, their ovaries produce eggs, allowing for genetic children via gestational surrogacy. Management often involves creating a functional vagina for sexual intercourse through non-surgical dilation or surgical vaginoplasty, alongside psychological support.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Lifelong, though symptoms (primary amenorrhea) typically manifest at puberty.
Duration of Illness (Lifetime)
Lifelong congenital condition.
Cost of Treatment (Initial)
Moderate to high, including diagnostic workup, psychological support, and potential surgical intervention (e.g., vaginoplasty), ranging from several thousands to tens of thousands of dollars.
Cost of Treatment (Lifetime)
Variable, encompassing follow-up care, potential repeat procedures, ongoing psychological support, and significant costs associated with gestational surrogacy if family planning is desired, potentially reaching hundreds of thousands of dollars.
Mortality Rate
Extremely low, primarily associated with potential rare complications from surgical interventions rather than the syndrome itself.
Risk of Secondary Damages
High, primarily psychological distress, body image issues, sexual dysfunction, and grief over infertility. Physical complications from surgical interventions are possible but generally manageable.
Probability of Full Recovery
No complete 'recovery' as it's a congenital anatomical malformation. Functional recovery for sexual activity is high with treatment (e.g., vaginoplasty or dilators), but uterine fertility is not restorable.
Underlying Disease Risk
Moderate, as MRKH can be associated with renal anomalies (e.g., absent or horseshoe kidney), skeletal abnormalities (e.g., vertebral defects), and, less commonly, hearing impairment (known as MURCS association).